Advertisement

Newborn anaesthesia: Pharmacological considerations

  • D. Ryan Cook
Article

Keywords

Fentanyl Halothane Succinylcholine Sufentanil Vecuronium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Brandom BW, Brandom RB, Cook DR. Uptake and distribution of halothane in infants: in vivo measurements and computer simulations. Anesth Analg 1983; 62:404–10.PubMedGoogle Scholar
  2. 2.
    Lerman J, Robinson S, Willis MM, Gregory GA. Anesthetic requirement for halothane in young children 0-1 month and 1-6 months of age. Anesthesiology 1983; 59:421–4.PubMedGoogle Scholar
  3. 3.
    Boudreaux P, Schieber RA, Cook DR. Hemodynamic effects of halothane in the newborn piglet. Anesth Analg 1984; 63:731–7.PubMedCrossRefGoogle Scholar
  4. 4.
    Ware R, Robinson S, Gregory GA. Effect of halothane on the baroreceptor response in newborn and adult rabbits. Anesthesiology 1982; 56:188–91.CrossRefGoogle Scholar
  5. 5.
    Duncan P, Gregory GA, Wade JA. The effects of nitrous oxide on the baroreceptor response of newborn and adult rabbits. Can Anesth Soc J 1981; 28:339–41.CrossRefGoogle Scholar
  6. 6.
    Cook DR, Brandom BW, Shiu G, Wolfson B. The inspired median effective dose, brain concentration at anesthesia, and cardiovascular index for halothane in young rats. Anesth Analg 1981; 60:182–5.PubMedCrossRefGoogle Scholar
  7. 7.
    Cook DR. Pediatric anesthetic pharmacology: a review. Drugs 1976; 12:212.PubMedCrossRefGoogle Scholar
  8. 8.
    Koehntop D, Rodman J, Brundage D, Hegland M, Buckley J. Pharmacokinetics of fentanyl in neonates. Anesthesiology 1984; 61:A439.CrossRefGoogle Scholar
  9. 9.
    Singleton MA, Rosen JI, Fisher DM. Pharmacokinetics of fentanyl for infants and adults. Anesthesiology 1984; 61:A440.CrossRefGoogle Scholar
  10. 10.
    Johnson KL, Erickson JP, Holley FO, Scott JC. Fentanyl pharmacokinetics in the pédiatrie population. Anesthesiology 1984; 61:A441.CrossRefGoogle Scholar
  11. 11.
    Collins G, Koren G, Crean P, Klein J, Ray WL, MacLeod SM. The correlation between fentanyl pharmacokinetics and pharmacodynamics in preterm infants during PDA ligation. Anesthesiology 1984; 61:A442.CrossRefGoogle Scholar
  12. 12.
    Hickey PR, Hansen DD. Fentanyl and sufentanil-oxygen-pancuronium anesthesia for cardiac surgery in infants. Anesth Analg 1984; 63:117–24.PubMedGoogle Scholar
  13. 13.
    Hickey PR, Hansen DD, Wessell D. Responses to high dose fentanyl in infants: pulmonary and systemic hemodynamics. Anesthesiology 1984; 61:A445.CrossRefGoogle Scholar
  14. 14.
    Schieber RA, Stiller RL, Cook DR. Cardiovascular and pharmacodynamic effects of high-dose fentanyl in newborn piglets. Anesthesiology 1985; 63:166–71.PubMedCrossRefGoogle Scholar
  15. 15.
    Koren G, Crean P, Goresky G, Klein J, MacLeod SM. Fentanyl anesthesia for cardiac surgery in children: a) fentanyl-oxygen vs. fentanyl-N2O; b) relationship between drug concentrations and pharmacodynamics. Anesthesiology 1984; 61:A444.CrossRefGoogle Scholar
  16. 16.
    Hickey PR, Hansen DD. Fentanyl and sufentanil-oxygen-pancuronium anesthesia for cardiac surgery in infants. Anesth Analg 1984; 63:117–24.PubMedGoogle Scholar
  17. 17.
    Davis PJ, Robinson KA, Stiller RL, Cook DR. Sufentanil kinetics in infants and children. Anesthesiology 1985; 63:A472.CrossRefGoogle Scholar
  18. 18.
    Cook DR. Muscle relaxants in infants and children. Anesth Analg 1981; 60:335–40.PubMedGoogle Scholar
  19. 19.
    Cook DR, Westman HR, Rosenfeld L, Hendershol RJ. Pulmonary edema in infants: possible association with intramuscular succinylcholine. Anesth Analg 1981; 60:220–3.PubMedCrossRefGoogle Scholar
  20. 20.
    Goudsouzian NG, Donlon JV, Savarese JJ, Ryan JF. Re-evaluation of dosage and duration of action of d-tubocurarine in the pediatrie age group. Anesthesiology 1975; 43:416–25.PubMedCrossRefGoogle Scholar
  21. 21.
    Goudsouzian NG, Liu L, Savarese JJ. Metocurine in infants and children. Anesthesiology 1978; 49:226–9.CrossRefGoogle Scholar
  22. 22.
    Goudsouzian NG, Ryan JF, Savarese JJ. The neuromuscular effets of pancuronium in infants and children. Anesthesiology 1974; 41:95–8.PubMedCrossRefGoogle Scholar
  23. 23.
    Brandom BW, Rudd GD, Cook DR. Clinical pharmacology of atracurium (BW33A) in paediatric patients. Br J Anaesth 1983: 55:117S-121S.PubMedGoogle Scholar
  24. 24.
    Brandom BW, Woelfel SK, Cook DR, Fehr B, Rudd D. Clinical pharmacology of atracurium in infants. Anesth Analg 1984; 63:309–12.PubMedCrossRefGoogle Scholar
  25. 25.
    Goudsouzian NG, Liu LMP, Cote CJ, Gionfriddo M, Rudd GD. Safety and efficacy of atracurium in adolescents and children anesthetized with halothane. Anesthesiology (in press).Google Scholar
  26. 26.
    Goudsouzian NG, Martyn J, Liu LMP, Giofriddo M. Safety and efficacy of vercuronium in adolescents and children. Anesth Analg (in press).Google Scholar
  27. 27.
    Fisher DM, Miller RD. Neuromuscular effects of vecuronium (ORGNC45) in infants and children during N2O, halothane anaesthesia. Anesthesiology (in press).Google Scholar

Copyright information

© Canadian Anesthesiologists 1986

Authors and Affiliations

  • D. Ryan Cook
    • 1
  1. 1.Children’s Hospital of PittsburghUniversity of Pittsburgh School of MedicinePittsburgh

Personalised recommendations